<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01817556</url>
  </required_header>
  <id_info>
    <org_study_id>DA9601_Gas_IV</org_study_id>
    <nct_id>NCT01817556</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab.</brief_title>
  <official_title>A Multicenter, Active-controlled, Randomized, Double-blind Paralleled-group Clinical Trial to Evaluate the Efficacy of 4-week Treatment With Stillen Tab. in Patients With Acute or Chronic Gastritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dong-A Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dong-A ST Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter, active-controlled, randomized, double-blinded, paralleled group
      clinical study to evaluate the efficacy of 4-week treatment with Stillen tab. in patients
      with acute or chronic gastritis. Subject will receive Stillen tab or Mucosta tab., three
      times a day for four weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement rates of erosive gastritis</measure>
    <time_frame>4 weeks</time_frame>
    <description>Improvement rates of erosive gastritis (%)
= (improved cases)/(total cases administered) * 100</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Healing rates of erosive gastritis</measure>
    <time_frame>4 weeks</time_frame>
    <description>Healing rates of erosive gastritis (%)
= (healed cases)/(total cases administered)*100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptoms improved level</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">258</enrollment>
  <condition>Acute Gastritis</condition>
  <condition>Chronic Gastritis</condition>
  <arm_group>
    <arm_group_label>Stillen Tab.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>administered three times daily for four weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mucosta Tab.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>administered three times daily for four weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Stillen Tab.</intervention_name>
    <arm_group_label>Stillen Tab.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mucosta Tab.</intervention_name>
    <arm_group_label>Mucosta Tab.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age is over 20 years old, under 75 years old, men or women

          -  Patients diagnosed with acute or chronic gastritis by gastroscopy

          -  Patients with one or more erosions found by gastroscopy

          -  Signed the informed consent forms

        Exclusion Criteria:

          -  Patients with peptic ulcer and gastroesophageal reflux disease

          -  Patients administered with prokinetics, H2 receptor antagonists, proton pump
             inhibitors, anticholinergic drugs or non-steroid anti-inflammatory drugs prior to
             study in 2 weeks

          -  Patients with surgery related to gastroesophageal

          -  Patients with Zollinger-Ellison syndrome

          -  Patients with any kind of malignant tumor

          -  Patients administered with anti-thrombotic drugs

          -  Patients with significant cardiovascular, pulmonary, heptic, renal, hemopoietic or
             endocrine system primary disease

          -  Women either pregnant or breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yong Chan Lee, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yonsei University, Severance Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jin Il Kim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University, Yeouido St. Mary's Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kwang Ro Joo, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyung Hee University Gangdong Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dong Il Park, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kangbuk Samsung Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>In Kyung Sung, M.D.,Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Konkuk University Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kyu Chan Huh, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Konyang University Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jung Il Suh, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dongguk University Gyeongju Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Su Jin Hong, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soon Chun Hyang University Bucheon Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jin Heung Kim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dae Hwan Kang, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pusan National University Yangsan Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tae Joo Jeon, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University Sanggye Paik Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tea Oh Kim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University Haeundae Paik Hospital of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hyun Yong Jeong, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chungnam National Unviersity Hospital of Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yonsei University Health System, Severance Hospital, IRB</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2013</study_first_submitted>
  <study_first_submitted_qc>March 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2013</study_first_posted>
  <last_update_submitted>November 5, 2013</last_update_submitted>
  <last_update_submitted_qc>November 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastritis</mesh_term>
    <mesh_term>Gastritis, Atrophic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

